Ibandronate (as sodium) 3mg/3mL; soln for IV inj. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone ...
Oct. 8, 2003 — Intermittent ibandronate for prevention of osteoporosis is effective and well tolerated, according to the results of a study published in the October issue of the Annals of Rheumatic ...
Roche announced the results from the first year of a phase III study (DIVA) investigating an intravenous injection of Bonviva/Boniva (ibandronate) with extended intervals between dosages, for the ...
SAN FRANCISCO (MarketWatch) -- Roche and GlaxoSmithKline Plc said late Friday the Food and Drug Administration has approved Boniva Injection, the first intravenous medication for the treatment of ...
Roche and GlaxoSmithKline have submitted a new drug application (NDA) with the US FDA for a novel, intermittent intravenous (IV) injection formulation of bisphosphonate Boniva (ibandronate sodium) for ...
An intravenous (IV) injection is an injection of a medication or another substance into a vein and directly into the bloodstream. It is one of the fastest ways to get a drug into the body, often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results